Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Elucidating in-situ small molecule-RNA interactions by proximal reverse transcription-based sequencing

Descrizione del progetto

Mappatura dei farmaci mirati all’RNA

Lo splicing dell’RNA è una fase centrale dell’espressione genica, in cui le sequenze non codificanti (introni) vengono rimosse da pre-mRNA prima che possa avvenire la sintesi proteica. I difetti di splicing dell’RNA sono alla base di molte malattie genetiche e intervenire su questa via sta destando estremo interesse come strategia terapeutica. Tuttavia, comprendere come le piccole molecole si leghino selettivamente all’RNA o alle proteine leganti l’RNA (RBP) rimane una sfida importante. Con il sostegno del programma di azioni Marie Skłodowska-Curie, il progetto SMART-RT si propone di sviluppare un metodo innovativo per mappare le interazioni di piccole molecole con RNA e RBP nelle cellule. Ciò fornirà importanti informazioni sulla biologia dell’RNA e dovrebbe accelerare la scoperta di farmaci mirati all’RNA per varie condizioni genetiche.

Obiettivo

RNA is vital for cellular processes that include transcription, translation, and gene expression, making it an attractive drug target. However, deciphering the selective interaction between small molecules and RNA remains challenging due to RNA's dynamic structure and limited chemical functionality. Although FDA-approved drugs like Evrysdi have demonstrated the therapeutic potential of RNA binding small molecules, precise and reliable methods for targeting the interactions remain underdeveloped. This project aims to develop a Small Molecule-Assisted RNA Targeting and Reverse Transcription (SMART-RT) method to address this important challenge. The primary objective of SMART-RT is to create an in-situ interaction map of small molecules that interact with RNA or RNA-associated proteins (RBPs) in live cells. This innovative method will use RNA/RBP-binding small molecules to induce proximal reverse transcription (RT), enabling precise and sensitive mapping of RNA sequences and their interactions in their native cellular environment through downstream sequencing. By overcoming the limitations of current methods, SMART-RT will offer a detailed map of RNA/RBP interactions with small molecules, providing new insights and opportunities for the targeting of RNA biology and facilitating the discovery of novel therapeutics. This multidisciplinary project combines chemical biology, molecular biology, and medicinal chemistry to map RNA/RBP-small molecule interactions, using cutting-edge biotechnology for scientific exploration. It leverages my expertise in biochemistry and medicinal chemistry, providing extensive RNA technology training and fostering interdisciplinary collaborations. Aligned with MSCA’s goals of promoting innovation and knowledge transfer, the project will advance scientific discovery and technological development. Awarded MSCA Fellow will boost my research independence and equip me as group leader in biotechnology, enabling significant contributions to the field.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-MSCA-2024-PF-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
Contributo netto dell'UE
€ 276 187,92
Indirizzo
TRINITY LANE THE OLD SCHOOLS
CB2 1TN CAMBRIDGE
Regno Unito
Regione
East of England East Anglia Cambridgeshire CC
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
Nessun dato